Depressive symptoms, psychiatric medication use, and risk of type 2 diabetes: Results from the Health and Retirement Study

General Hospital Psychiatry

Volumn 37, Issue 5, 2015, Pages 420-426

  Ratliff, Scott ^a   Mezuk, Briana ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antidepressants; Depression; Epidemiology; Longitudinal; Type 2 diabetes

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

8 ITEM CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; SYMPTOM; TREATMENT RESPONSE; WEIGHT GAIN; COMPLICATION; DIABETES MELLITUS, TYPE 2; QUESTIONNAIRE;

ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SURVEYS AND QUESTIONNAIRES;

EID: 84941260275     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.05.008     Document Type: Article

References (36)

1. Olfson M., Marcus S. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009, 66:848-856.
2. Middleton N., Gunnell D., Whitley E., Dorling D., Frankel S. Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med 2001, 23:262-267.
3. Moore M., Yuen H.M., Dunn N., Mullee M.A., Maskell J., Kendrick T. Explaining the rise in antidepressant prescribing: A descriptive study using the general practice research database. BMJ 2009, 10.1136/bmj.b3999.
4. Gonzlez H., Tarraf W., Whitfield K., Vega W. The epidemiology of major depression and ethnicity in the United States. J Psychiatr Res 2010, 44:1043-1051.
5. Kessler R.C., Birnbaum H., Bromet E., Hwang I., Sampson N., Shahly V. Age differences in major depression: Results from the national comorbidity survey replication (NCS-R). Psychol Med 2010, 40:225-237.
6. Results from the 2010 national survey on drug use and health: Mental health findings. NSDUH Series H-42, HHS Publication No. (SMA) 2012, 11-4667. Substance Abuse and Mental Health Services Administration.
7. Mezuk B., Eaton W.W., Albrecht S., Golden S.H. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care 2008, 31:2383-2390.
8. Golden S.H., Lazo M., Carnethon M., Bertoni A.G., Schreiner P.J., Diez Roux A.V., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008, 299:2751-2759.
9. Pan A., Lucas M., Sun Q., van Dam R.M., Franco O.H., Manson J.E., et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 2010, 170:1884-1891.
10. Strine T., Mokdad A., Dube S., Balluz L.S., Gonzalez O., Berry J.T., et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry 2008, 30:127-137.
11. Champaneri S., Wand G.S., Malhotra S.S., Casagrande S.S., Golden S.H. Biological basis of depression in adults with diabetes. Curr Diab Rep 2010, 10:396-405.
12. Golden S. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev 2007, 3:252-259.
13. DeSantis A.S., DiezRoux A.V., Hajat A., Golden S.H., Jenny N.S., Sanchez B.N., et al. Associations of salivary cortisol levels with metabolic syndrome and its components: The multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab 2011, 96:3483-3492.
14. Barnard K., Peveler R.C., Holt R.I. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: Systematic review. Diabetes Care 2013, 36:3337-3345.
15. Pan A., Sun Q., Okereke O.I., Rexrode K.M., Rubin R.R., Lucas M., et al. Use of antidepressant medication and risk of type 2 diabetes: Results from three cohorts of US adults. Diabetologia 2012, 55:63-72.
16. Kivimaki M., Tabak A.G., Batty G.D., Singh-Manoux A., Jokela M., Akbaraly T.N., et al. Hyperglycemia, type 2 diabetes, and depressive symptoms: The British Whitehall II Study. Diabetes Care 2009, 32:1867-1869.
17. Rubin R.R., Ma Y., Marrero D.G., Peyrot M., Barrett-Connor E.L., Kahn S.E., et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008, 31:420-426.
18. Rubin R.R., Ma Y., Peyrot M., Marrero D.G., Price D.W., Barrett-Connor E., et al. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care 2010, 33:2549-2551.
19. Ma Y., Balasubramanian R., Pagoto S., Schneider K.L., Culver A.L., Olendzki B., et al. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women. Diabetes Care 2011, 34:2390-2392.
20. Vimalananda V.G., Palmer J.R., Gerlovin H., Wise L.A., Rosenzweig J.L., Rosenberg L., et al. Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study. Diabetes Care 2014, 37:2211-2217.
21. Lustman P., Freedland K., Griffith L.S., Clouse R. Fluoxetine for depression in diabetes: A randomized double-blind placebo-controlled trial. Diabetes Care 2000, 23:618-623.
22. Lustman P.J., Clouse R.E., Nix B.D., Freedland K.E., Rubin E.H., McGill J.B., et al. Sertraline for prevention of depression recurrence in diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521-529.
23. Ye Z., Chen L., Yang Z., Li Q., Huang Y., He M., et al. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials. PLoS One 2011, 6:e21551.
24. Juster F.T., Suzman R. An overview of the Health and Retirement Study. J Hum Resour 1995, 30:S7-S56.
25. Steffick D.E. Documentation of affective functioning measures in the Health and Retirement Study Available from, [accessed 17 June 2014]. http://hrsonline.isr.umich.edu/index.php.
26. Roberts R.E., Vernon S.W. The Center for Epidemiologic Studies Depression Scale: Its use in a community sample. Am J Psychiatry 1983, 140:41-46.
27. Turvey C.L., Wallace R.B., Herzog R. A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr 1999, 11:139-148.
28. Mojtabai R., Olfson M. Major depression in community-dwelling middle-aged and older adults: Prevalence and 2- and 4-year follow-up symptoms. Psychol Med 2004, 34:623-634.
29. 2005 Prescription Drug Study. Produced and distributed by the University of Michigan with funding from the National Institute on Aging (grant number NIA U01AG009740). Ann Arbor, MI 2006, Health and Retirement Study.
30. Chapter 3 - Foods and Food Components to Reduce. Dietary Guidelines for Americans, 2010 2010, 30-32. U.S. Department of Agriculture, U.S. Department of Health and Human ServicesU.S. Department of Health and Human Services, US Government Printing Office, Washington, DC. 7th ed.
31. Selvin S. Statistical analysis of epidemiologic data 2004, Oxford University Press, New York, NY. 3rd edit.
32. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States 2014, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA.
33. Crimmins E., Guyer H., Langa K., Ofstedal M.B., Wallace R., Weir D. Documentation of biomarkers in the Health and Retirement Study. HRS Documentation Report 2008, [Available from http://hrsonline.isr.umich.edu/sitedocs/userg/HRS2006BiomarkerDescription.pdf, accessed 29 May 2014].
34. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69. American Diabetes Association.
35. Wacholder S., Hartge P., Lubin J.H., Dosemeci M. Non-differential misclassification and bias towards the null: A clarification. Occup Environ Med 1995, 52:557-558.
36. Campayo A., de Jonge P., Roy J.F., Saz P., de la Camara C., Quintanilla M.A., et al. Depressive disorder and incident diabetes mellitus: The effect of characteristics of depression. Am J Psychiatry 2010, 167:580-588.